Advanced genetic testing that helps providers identify individual risk for addiction.
Stop addiction before it starts.
LifeKit® Predict is a DNA test that helps providers predict a patient's risk of developing an addiction to opioids.
Simple, quickly analyzed swab test administered before opioid exposure
Provides assurance—with 97% sensitivity—that an individual may not have increased genetic risk for opioid dependency1
Can identify—with 87% specificity—that someone may have an increased risk for opioid dependency1
The LifeKit® Predict test uses 16 alleles involved in the brain-reward pathway in individuals with and without addiction.
With predictive insight, physicians can choose alternative non-opioid therapies for patients at risk for opioid dependency.
LifeKit® Predict provides assurance—with 97% sensitivity—that an individual may not have increased genetic risk for opioid dependency.1
Together, we can solve the opioid crisis.
By translating genetic information into predictive intelligence, we empower healthcare providers to identify individual risk for addiction and screen for potential reactions. The results: better outcomes and lower costs.
Donaldson K, Demers L, Taylor K, Lopez J, Chang S. Multi-variant genetic panel for genetic risk of opioid addiction. Ann Clin Lab Sci. 2017;47(4):452-456.